Neuroendocrine Prostate Cancer Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Neuroendocrine Prostate Cancer Market is segmented By Treatment (Chemotherapy, Hormonal Therapy), By Stage of Disease (Localized, Metastatic), By Therapeutics (Immunotherapy, Targeted Therapy), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Million) for the above-mentioned segments.

Neuroendocrine Prostate Cancer Market Leaders

  • Amgen
  • BioXcel Therapeutics
  • Oric Pharmaceuticals
  • Xencor
  • Astellas Pharma/Medivation
*Disclaimer: Major players are listed in no particular order.

Neuroendocrine Prostate Cancer Market - Company List

  • Amgen
  • BioXcel Therapeutics
  • Oric Pharmaceuticals
  • Xencor
  • Astellas Pharma/Medivation
  • Novartis
  • Pfizer
  • Amgen
  • Merck
  • Bayer